Comparison

(R)-Zanubrutinib European Partner

Item no. HY-101474B-100mg
Manufacturer MedChem Express
CASRN 1691249-44-1
Amount 100 mg
Quantity options 100 mg 10mM/1mL 10 mg 1mg 25 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 97.08
Formula C27H29N5O3
Citations [1]Wu J, et al. Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor. J Hematol Oncol. 2016 Mar 9;9:21.<br/>[2]Wu J, et al. Second-generation inhibitors of Bruton tyrosine kinase. J Hematol Oncol. 2016 Sep 2;9(1):80.
Smiles NC(C1=C2N(N=C1C3=CC=C(OC4=CC=CC=C4)C=C3)[C@@H](C5CCN(C(C=C)=O)CC5)CCN2)=O
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias (R)-BGB-3111
Available
Product Description
(R)-Zanubrutinib is the R enantiomer of Zanubrutinib (HY-101474A). (R)-Zanubrutinib inhibits Bruton's tyrosine kinase (Btk) with an IC50 of 11 nM.
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
MolecularWeight
471.55
Clinical Information
No Development Reported
Manufacturers Research Area
Others
Solubility
DMSO : ≥ 64.25 mg/mL
Target
Btk
Manufacturers Target
Btk
Manufacturers Pathway
Protein Tyrosine Kinase/RTK
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close